JBC Advanced Peptides, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M504815200 on May 17, 2005

J. Biol. Chem., Vol. 280, Issue 27, 25506-25511, July 8, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/27/25506    most recent
M504815200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Devlin, A. M.
Right arrow Articles by Lentz, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Devlin, A. M.
Right arrow Articles by Lentz, S. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Tissue-specific Changes in H19 Methylation and Expression in Mice with Hyperhomocysteinemia*

Angela M. Devlin{ddagger}§, Teodoro Bottiglieri¶, Frederick E. Domann||, and Steven R. Lentz{ddagger}**{ddagger}{ddagger}

From the Departments of {ddagger}Internal Medicine and|| Radiation Biology, University of Iowa Carver College of Medicine, Iowa City, Iowa 52242, the** Veterans Affairs Medical Center, Iowa City, Iowa 52246, and the Baylor Institute of Metabolic Disease, Dallas, Texas 75226

Expression of the imprinted genes H19 and insulin-like growth factor 2 (Igf2), which lie in close proximity on mouse chromosome 7, is regulated by methylation of a differentially methylated domain (DMD) located 5' to H19. Biallelic expression of H19 has been observed in renal disease patients with hyperhomocysteinemia, a cardiovascular disease risk factor. The present study determined whether hyperhomocysteinemia produces decreased tissue methylation capacity, hypomethylation of the H19 DMD, and altered expression of H19 and Igf2 in adult mice. Mice heterozygous for disruption of the gene for cystathionine-{beta}-synthase (Cbs+/–) and C57BL/6 (Cbs+/+) mice were fed a hyperhomocysteinemic or control diet, respectively, from weaning until 9–12 months of age. Higher plasma total homocysteine (p < 0.001) was found in hyperhomocysteinemic mice than in control mice (95 ± 12 versus 5.0 ± 0.3 µmol/liter). Hyperhomocysteinemia was accompanied by higher levels of S-adenosylhomocysteine (p < 0.05) and lower S-adenosylmethionine/S-adenosylhomocysteine ratios (p < 0.001) in liver and brain. The effect of hyperhomocysteinemia on H19 DMD methylation was tissue-specific. In liver, hyperhomocysteinemic mice had decreased H19 DMD methylation (p < 0.001). In brain, hyperhomocysteinemia was accompanied by increased H19 DMD methylation (p < 0.001) and a decrease in the ratio of H19/Igf2 transcripts (p < 0.05). In aorta, hyperhomocysteinemia produced an increase in H19 DMD methylation (p < 0.001) and a 2.5-fold increase in expression of H19 transcripts (p < 0.05). Levels of H19 transcripts in aorta correlated positively with plasma total homocysteine concentration (p < 0.05, r = 0.620). We conclude that hyperhomocysteinemia produces tissue-specific changes in H19 DMD methylation and increased vascular expression of H19 in adult mice.


Received for publication, May 2, 2005 , and in revised form, May 17, 2005.

* This work was supported by the Office of Research and Development, United States Department of Veterans Affairs, National Institutes of Health Grants HL63943 and NS24621, and American Heart Association Beginning Grant-in-aid 0465315Z (to A. M. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Present address: Nutrition Research Program, University of British Columbia, BC Research Institute for Children's and Women's Health, 950 West 28th Ave., Vancouver, Canada.

{ddagger}{ddagger} To whom correspondence should be addressed: Dept. of Internal Medicine, C32 GH, The University of Iowa, IA 52242. Tel.: 319-356-4048; Fax: 319-335-8848; E-mail: steven-lentz{at}uiowa.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Dayal and S. R. Lentz
Murine Models of Hyperhomocysteinemia and Their Vascular Phenotypes
Arterioscler. Thromb. Vasc. Biol., September 1, 2008; 28(9): 1596 - 1605.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Dayal, R. N. Rodionov, E. Arning, T. Bottiglieri, M. Kimoto, D. J. Murry, J. P. Cooke, F. M. Faraci, and S. R. Lentz
Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia
Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H816 - H825.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P.-Y. Chang, S.-C. Lu, C.-M. Lee, Y.-J. Chen, T. A. Dugan, W.-H. Huang, S.-F. Chang, W. S.L. Liao, C.-H. Chen, and Y.-T. Lee
Homocysteine Inhibits Arterial Endothelial Cell Growth Through Transcriptional Downregulation of Fibroblast Growth Factor-2 Involving G Protein and DNA Methylation
Circ. Res., April 25, 2008; 102(8): 933 - 941.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A D. Smith, Y.-I. Kim, and H. Refsum
Is folic acid good for everyone?
Am. J. Clinical Nutrition, March 1, 2008; 87(3): 517 - 533.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Devlin, R. Singh, R. E. Wade, S. M. Innis, T. Bottiglieri, and S. R. Lentz
Hypermethylation of Fads2 and Altered Hepatic Fatty Acid and Phospholipid Metabolism in Mice with Hyperhomocysteinemia
J. Biol. Chem., December 21, 2007; 282(51): 37082 - 37090.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. Sontag, V. Nunbhakdi-Craig, J.-M. Sontag, R. Diaz-Arrastia, E. Ogris, S. Dayal, S. R. Lentz, E. Arning, and T. Bottiglieri
Protein Phosphatase 2A Methyltransferase Links Homocysteine Metabolism with Tau and Amyloid Precursor Protein Regulation
J. Neurosci., March 14, 2007; 27(11): 2751 - 2759.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Dayal, K. M. Wilson, L. Leo, E. Arning, T. Bottiglieri, and S. R. Lentz
Enhanced susceptibility to arterial thrombosis in a murine model of hyperhomocysteinemia
Blood, October 1, 2006; 108(7): 2237 - 2243.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. M. Devlin and S. R. Lentz
ApoA-I: A Missing Link Between Homocysteine and Lipid Metabolism?
Circ. Res., March 3, 2006; 98(4): 431 - 433.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.